Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 2, 2012, Pages 397-406

  Huang, K ^a   Li, S Q ^a   Wang, W J ^a   Liu, L S ^a   Jiang, Y G ^a   Feng, P N ^a   Wang, Y Q ^a   Wang, S M ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atherosclerosis; FTY720; Oral tolerance; Tregs

Indexed keywords

APOLIPOPROTEIN E; FINGOLIMOD; LATENCY ASSOCIATED PEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CHOLESTEROL DIET; CONTROLLED STUDY; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INHIBITION KINETICS; LOW DRUG DOSE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; TH1 CELL; ANIMAL CELL; CYTOKINE PRODUCTION; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE STRAIN; SPLEEN CELL;

EID: 84863670640     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500209     Document Type: Article

References (28)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-26.
2. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6:508-19. (Pubitemid 43980523)
3. Faria AM, Weiner HL. Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 2006; 13:143-57. (Pubitemid 44950033)
4. Zhang Z, Schluesener HJ. FTY720: a most promising immunosuppressant modulating immune cell functions. Mini Rev Med Chem 2007; 7:845-50. (Pubitemid 47304946)
5. Gollmann G, Neuwirt H, Tripp CH, Mueller H, Konwalinka G, Heufler C, Romani N, Tiefenthaler M. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell Chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions. Int Immunol 2008; 20:911-23. (Pubitemid 351865866)
6. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004; 4:1019-25. (Pubitemid 38868590)
7. Nofer JR, Bot M, Brodde M, et al. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in lowdensity lipoprotein receptor-deficient mice. Circulation 2007; 115:501-8. (Pubitemid 46188244)
8. Keul P, Tolle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27:607-13.
9. Daniel C, Sartory N, Zahn N, Geisslinger G, Radeke HH, Stein JM. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J Immunol 2007; 178:2458-68. (Pubitemid 46233446)
10. Sehrawat S, Rouse BT. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. J Immunol 2008; 180:7636-47.
11. Taylor PA, Ehrhardt MJ, Lees CJ, Tolar J, Weigel BJ, Panoskaltsis-Mortari A, Serody JS, Brinkmann V, Blazar BR. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood 2007; 110:3480-8. (Pubitemid 350106345)
12. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009; 120:1996-2005.
13. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87. (Pubitemid 351707693)
14. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J. Role of naturally occurring CD4 CD25 regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27:893-900. (Pubitemid 46606722)
15. Klingenberg R, Nofer JR, Rudling M, et al. Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27:2392-9. (Pubitemid 350203955)
16. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86:515-81.
17. Anderson AC, Lord GM, Dardalhon V, Lee DH, Sabatos-Peyton CA, Glimcher LH, Kuchroo VK. T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur J Immunol 2010; 40:859-66.
18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61. (Pubitemid 36222930)
19. +T cells. Nat Med 2006; 12:627-35.
20. Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes 2007; 56:2103-9. (Pubitemid 47195835)
21. + follicular helper T cells. J Immunol 2008; 181:6038-50.
22. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011; 241:241-59.
23. Man K, Ng KT, Lee TK, Lo CM, Sun CK, Li XL, Zhao Y, Ho JW, Fan ST. FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant 2005; 5:40-9. (Pubitemid 40095126)
24. He JH, Zhang HN, Lin ZB. Effect of 2-amino-2-[2-(4-octylphenyl) ethyl] propane-1,3-diolhydrochloride (FTY720) on immune liver injury in mice. World J Gastroenterol 2005; 11:573-6.
25. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160:5037-44. (Pubitemid 28215340)
26. + T-regulatory cells and enhances their functional activity. J Immunol 2005; 175:7973-80.
27. + regulatory T cells in NOD mice. Am J Reprod Immunol 2011; 66:349-62.
28. Zhou PJ, Wang H, Shi GH, Wang XH, Shen ZJ, Xu D. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro. Clin Exp Immunol 2009; 157:40-7.